Some individuals benefit from weekly injections, while others may only need them monthly
Ming-Lung Y, Chen PJ, Dai CY, Tsung-Hui H, Huang CF, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Lin HC, Kao JH, Chuang WL
And for those who want to avoid injections entirely, oral semaglutide or phentermine-topiramate are the strongest oral options
It is important to note that: Most clinical trials have follow-up periods of 25 years, which may not capture very long-term cancer development Patients with type 2 diabetes and obesity have baseline elevated cancer risks due to metabolic factors Post-marketing surveillance continues to monitor for rare or delayed adverse events The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) continue to review safety data as part of ongoing pharmacovigilance activities, and no major cancer-related safety signals have emerged that would warrant withdrawal or significant restriction of these medicines